ML21284A002
| ML21284A002 | |
| Person / Time | |
|---|---|
| Site: | SHINE Medical Technologies |
| Issue date: | 10/11/2021 |
| From: | Jim Costedio SHINE Health. Illuminated |
| To: | Document Control Desk, Office of Nuclear Reactor Regulation |
| References | |
| 2021-SMT-0143 | |
| Download: ML21284A002 (1) | |
Text
3400 Innovation Ct.
- Janesville, WI 53546
- 877.512.6554
- info@shinemed.com
- www.SHINEtechnologies.com October 11, 2021 2021-SMT-0143 10 CFR 50.30 U.S. Nuclear Regulatory Commission ATTN: Document Control Desk Washington, DC 20555
References:
(1) SHINE Medical Technologies, LLC letter to the NRC, SHINE Medical Technologies, LLC Application for an Operating License, dated July 17, 2019 (ML19211C143)
(2) NRC letter to SHINE Medical Technologies, LLC, SHINE Medical Technologies, LLC - Request for Additional Information Related to Cyber Security (EPID No. L-2019-NEW-0004), dated August 13, 2021 (ML21210A438)
SHINE Technologies, LLC Application for an Operating License Response to Request for Additional Information Pursuant to 10 CFR Part 50.30, SHINE Technologies, LLC (SHINE) submitted an application for an operating license for a medical isotope production facility to be located in Janesville, WI (Reference 1). The NRC staff determined that additional information was required to enable the staffs continued review of the SHINE operating license application (Reference 2).
Additional time is needed to prepare responses to the Reference 2 requests for additional information (RAIs). SHINE will submit responses to the Reference 2 RAIs by November 11, 2021.
If you have any questions, please contact Mr. Jeff Bartelme, Director of Licensing, at 608/210-1735.
Very truly yours, James Costedio Vice President of Regulatory Affairs and Quality SHINE Technologies, LLC Docket No. 50-608 cc:
Project Manager, USNRC SHINE General Counsel Supervisor, Radioactive Materials Program, Wisconsin Division of Public Health